Equities research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of CALA opened at $0.00 on Friday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.
Calithera Biosciences Company Profile
Featured Articles
- Five stocks we like better than Calithera Biosciences
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- ETF Screener: Uses and Step-by-Step Guide
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Insider Trades May Not Tell You What You Think
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
